Indeed, primary hyperparathyroidism is often diagnosed in women, in the first decade after menopause, consistent with the known skeletal action of estrogen that neutralizes the hypercalcemic effects of excess PTH in bone [15]. This evidence concerns the gene PTH and primary hyperparathyroidism.